Saikrishna Yendamuri is a Cardiology physician affiliated with Roswell Park Comprehensive Cancer Center. OpenAlex indexes 42 publications with 552 citations (h-index 8); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Testing the SurVaxM Vaccine for Lung Cancer Prevention
Sponsor: National Cancer Institute (NCI)
Overall officialPhase 2Not, yet, recruitingNCT07169617 - Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer
Sponsor: Northwestern University
Overall officialPhase 2Active, not recruitingNCT04931017 - Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease
Sponsor: Roswell Park Cancer Institute
Overall officialPhase 1TerminatedNCT04836429
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
1 company with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
NIH funding
3 NIH research awards on record, funded 2011–2025 per NIH RePORTER. The latest:
- Metformin for chemoprevention of lung cancer in obese subjects at high risk
Roswell Park Cancer Institute Corp
FY2025$583,338R01CA255515 - Metformin for chemoprevention of lung cancer in obese subjects at high risk
Roswell Park Cancer Institute Corp
FY2024$628,294R01CA255515 - Metformin for chemoprevention of lung cancer in obese subjects at high risk
Roswell Park Cancer Institute Corp
FY2024$66,036R01CA255515
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip McCarthy, MD
Roswell Park Comprehensive Cancer Center
Saby George, MD
Roswell Park Comprehensive Cancer Center
Eunice Wang, MD
Roswell Park Comprehensive Cancer Center
Shashikant Lele, MD
Roswell Park Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”